Duration of Chemotherapy for Early Stage Breast Cancer: Have We Reached the Limit? What is the Survival Impact of Amenorrhea?

Author： Hirsh Rebecca  

Publisher： Springer Publishing Company

ISSN： 1527-2729

Source： Current Treatment Options in Oncology, Vol.11, Iss.3-4, 2010-12, pp. : 59-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fatigue, Weight Gain, Lethargy and Amenorrhea in Breast Cancer Patients on Chemotherapy: Is Subclinical Hypothyroidism the Culprit?

By Kumar Nagi  

Breast Cancer Research and Treatment, Vol. 83, Iss. 2, 2004-01 ,pp. : 149-159

Springer Publishing Company

Access to resources Recommend Favorite

Tomato-based food products for prostate cancer prevention: what have we learned?

By Tan Hsueh-Li  

Cancer and Metastasis Reviews, Vol. 29, Iss. 3, 2010-09 ,pp. : 553-568

Springer Publishing Company

Access to resources Recommend Favorite

Thyroid cancer pooled analysis from 14 case–control studies: what have we learned?

By Preston‐Martin Susan  

Cancer Causes and Control, Vol. 14, Iss. 8, 2003-01 ,pp. : 787-789

Springer Publishing Company

Access to resources Recommend Favorite

Are we missing the mTOR target in breast cancer?

By Johnston Stephen  

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 607-611

Springer Publishing Company

Access to resources Recommend Favorite

Axillary lymph node dissection in early-stage invasive breast cancer: is it still standard today?

By Gerber Bernd  

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 613-624

Springer Publishing Company

Access to resources Recommend Favorite